Find

Institut for Klinisk Medicin

Infectious Diseases

Publikationer

Sortér efter: Dato | Forfatter | Titel

Jensen, K. M., Melchjorsen, J., Dagnaes-Hansen, F., Sørensen, U. B. S., Laursen, R. R., Østergaard, L. J., Søgaard, O. S. & Tolstrup, M. (2012). Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice. Microcosm - I I I, 80(5), 1744-52. https://doi.org/10.1128/IAI.00079-12

Reinert, L. S., Harder, L., Holm, C. K., Iversen, M. B., Horan, K. A., Dagnæs-Hansen, F., Ulhøi, B. P., Holm, T. H., Mogensen, T. H., Owens, T., Nyengaard, J. R., Thomsen, A. R. & Paludan, S. R. (2012). TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. Journal of Clinical Investigation. https://doi.org/10.1172/JCI60893

Offersen, R., Melchjorsen, J., Paludan, S. R., Østergaard, L. J., Tolstrup, M. & Søgaard, O. S. (2012). TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults. Human Vaccines & Immunotherapeutics, 8(8), 1042-7. https://doi.org/10.4161/hv.20707

Christensen, P. B., Clausen, M. R., Krarup, H., Laursen, A. L., Schlichting, P. & Weis, N. (2012). Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011. Danish Medical Bulletin (Online), 59(6), C4465.

Jespersen, S., Hønge, B. L., Medina, C., Té, D. D. S., Oliviera, I., Laursen, A. L., Østergaard, L. J. & Wejse, C. (2012). Treatment of HIV-2 in Guinea-Bissau – room for improvement.. Poster-session præsenteret på 29th Annual Meeting Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID) , Helsinki, Finland.

Rodkjær, L. Ø. & Laursen, T. (2012). Unge HIV-smittede knækker koden. Ungegruppen for hiv-smittede mellem 15-25 år.2012.

Dalgaard, L. S., Søgaard, O. S., Jensen-Fangel, S., Larsen, C. S., Sönnerborg, A. & Østergaard, L. J. (2012). Use of InfCare HIV to identify and characterize suboptimally treated HIV patients at a Danish HIV clinic: A cross-sectional cohort study. Scandinavian Journal of Infectious Diseases, 44(2), 108-14. https://doi.org/10.3109/00365548.2011.616223

Rasmussen, T. A., Jørgensen, M., Bjerrum, S., Jensen-Fangel, S., Støvring, H., Østergaard, L. J. & Søgaard, O. S. (2012). Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study. BMJ, 345, e5823. https://doi.org/10.1136/bmj.e5823

Rabna, P., Andersen, A., Wejse, C., Oliveira, I., Gomes, V. F., Haaland, M. B., Aaby, P. & Eugen-Olsen, J. (2012). Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment. PLoS One, 7(8), e43933. https://doi.org/10.1371/journal.pone.0043933

Østergaard, L. J., Wejse, C., Pærregaard, A., Böttiger, B. E., Kallestrup, P., Andersen, B. S., Hoxer, C. S., Udsen, F. W., Kidholm, K., Reerman, D., Holt, L., Petersen, B. H., Mortensen, A. B. & Svane, S. F. (2012). Vaccination mod rotavirus - en medicinsk teknologivurdering. I Medicinsk Teknologivurdering Sundhedsstyrelsen. http://sundhedsstyrelsen.dk/publ/Publ2012/06juni/MTV-RotavirusMedBilag.pdf

Viser resultater 1591 til 1600 ud af 2049

160

Revideret 11.09.2025

-

Lotte Bjerregaard Snabe